icon
0%

Schlumberger Limited SLB - News Analyzed: 3,995 - Last Week: 100 - Last Month: 500

↑ Schlumberger Limited SLB: A Strong Bio-Tech Contender Amid Robust Growth Prospects and Successful Q3 Results

Schlumberger Limited SLB: A Strong Bio-Tech Contender Amid Robust Growth Prospects and Successful Q3 Results
There's a significant focus on Schlumberger Limited (SLB), with many industry experts highlighting its robust potential. Jim Cramer twice labeled it as the 'best of breed,' though he noted that the stock hasn't risen as much as anticipated. Despite assertions of slowing growth, the company's Q3 profit surpassed predictions. However, Q4 revenue is anticipated to be modest. Analysts recognized SLB's appeal as a bargain stock and highlighted its growth in digital services and long-cycle projects. There's speculation on the potential for energy innovation through AI and strong growth prospects. Attention is also drawn to SLB's sale of Palliser block shares in Alberta and the acquisition of SLB shares by various investment firms. AI innovations and a potential $30 trillion opportunity were also pointed out. Another significant feature was the announcement of the Q3 2024 results revealing strong cash flow and margin expansion.

Schlumberger Limited SLB News Analytics from Wed, 17 Apr 2024 07:00:00 GMT to Sat, 19 Oct 2024 16:41:41 GMT - Rating 7 - Innovation 8 - Information 8 - Rumor 3

The email address you have entered is invalid.